HOOKIPA Pharma Inc. Banner Image

HOOKIPA Pharma Inc.

  • Ticker HOOK
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
HOOKIPA Pharma Inc. Logo Image
  • 51-200 Employees
  • Based in Vienna, Austria
HOOKIPA Pharma Inc. (NASDAQ: HOOK) is a clinical stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that reprograms the body’s immune system. HOOKIPA’s proprietary arenavirus-based technologies, non-replicating (VaxWave®) and replicating (TheraT®), induce robust antigen-specificMore CD8+ T cells and pathogen-neutralizing antibodies. HOOKIPA’s “off-the-shelf” viral vectors target antigen presenting cells in vivo to activate the immune system. Both technologies enable repeat administration to augment and refresh immune responses. As a monotherapy, their replicating arenavirus technology has the potential to induce CD8+ T cell response levels previously not achieved by other immuno-therapy approaches.
4.8 / 5.0 (205)

HOOKIPA Pharma Inc. reports have an aggregate usefulness score of 4.8 based on 205 reviews.

HOOKIPA Pharma Inc.

Most Recent Annual Report

HOOKIPA Pharma Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

HOOKIPA Pharma Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!